BALOXAVIR MARBOXIL vs BARICITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BALOXAVIR MARBOXIL vs BARICITINIB: Safety Overview
| Metric | BALOXAVIR MARBOXIL | BARICITINIB |
|---|---|---|
| Total FAERS Reports | 2,010 | 8,108 |
| Deaths Reported | 120 | 717 |
| Death Rate | 6.0% | 8.8% |
| Hospitalizations | 378 | 2,498 |
| Average Patient Age | 37.8 yrs | 58.2 yrs |
| % Female Patients | 53.8% | 67.9% |
| FDA Approval Date | Mar 18, 2021 | Aug 8, 2025 |
| Manufacturer | Genentech, Inc. | Eli Lilly and Company |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |